[Hemodynamics and metabolic parameters after administration of amrinone in patients with coronary heart disease].
Saborowski
F
F
Medizinische Klinik, Krankenhauses Köln-Holweide.
Griebenow
R
R
Lessing
P
P
D000136:Acid-Base Equilibrium / Q000187:drug effects / Q000502:physiology; D000676:Amrinone / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004734:Energy Metabolism / Q000187:drug effects* / Q000502:physiology; D004837:Epinephrine / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D019344:Lactic Acid; D000676:Amrinone; D009638:Norepinephrine; D004837:Epinephrine
Hämodynamik und metabolische Parameter nach Gabe von Amrinon bei Patienten mit koronarer Herzkrankheit.